4acp: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "4acp" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:4acp.jpg|left|200px]] | |||
The | <!-- | ||
The line below this paragraph, containing "STRUCTURE_4acp", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
--> | |||
{{STRUCTURE_4acp| PDB=4acp | SCENE= }} | |||
===Deactivation of human IgG1 Fc by endoglycosidase treatment=== | |||
<!-- | |||
The line below this paragraph, {{ABSTRACT_PUBMED_22484364}}, adds the Publication Abstract to the page | |||
(as it appears on PubMed at http://www.pubmed.gov), where 22484364 is the PubMed ID number. | |||
--> | |||
{{ABSTRACT_PUBMED_22484364}} | |||
==About this Structure== | |||
[[4acp]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ACP OCA]. | |||
==Reference== | |||
<ref group="xtra">PMID:022484364</ref><references group="xtra"/> | |||
[[Category: Homo sapiens]] | |||
[[Category: Bowden, T A.]] | |||
[[Category: Crispin, M.]] | |||
[[Category: Dwek, R A.]] | |||
[[Category: Krishna, B A.]] | |||
[[Category: Raman, K.]] | |||
[[Category: Scanlan, C N.]] | |||
[[Category: Antibody]] | |||
[[Category: Igg]] | |||
[[Category: Immune system]] | |||
[[Category: Kifunensine]] | |||
Revision as of 09:14, 25 April 2012
Deactivation of human IgG1 Fc by endoglycosidase treatment
Template:ABSTRACT PUBMED 22484364
About this Structure
4acp is a 2 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Baruah K, Bowden TA, Krishna BA, Dwek RA, Crispin M, Scanlan CN. Selective Deactivation of Serum IgG: A General Strategy for the Enhancement of Monoclonal Antibody Receptor Interactions. J Mol Biol. 2012 Apr 5. PMID:22484364 doi:10.1016/j.jmb.2012.04.002
